Matt Foehr is the founder of OmniAb, Inc.. OmniAb, Inc. has raised $95M in total funding. Latest round: IPO. Based in Emeryville, CA, United States.
Matthew W. Foehr is the President and Chief Executive Officer and a member of the Board of Directors of OmniAb, Inc. OmniAb became an independent publicly traded company on November 2, 2022, following a spin-off from Ligand Pharmaceuticals and a business combination with Avista Public Acquisition Corp. II. The company expects to have approximately $95 million in cash at closing. Mr. Foehr has over 25 years of pharmaceutical industry experience and previously served as President and Chief Operating Officer at Ligand Pharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library